BECCIOLINI, ANDREA

BECCIOLINI, ANDREA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 20 di 20 (tempo di esecuzione: 0.008 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritis 2019 Crotti C.Biggioggero M.Becciolini A.Agape E.Favalli E. G. Article (author) -
Sex and Management of Rheumatoid Arthritis 2019 Favalli E. G.Biggioggero M.Crotti C.Becciolini A.Raimondo M. G.Meroni P. L. Article (author) -
Tocilizumab in the treatment of rheumatoid arthritis : An evidence-based review and patient selection 2019 Biggioggero M.Crotti C.Becciolini A.Favalli E. G. Article (author) -
Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects 2019 Crotti C.Agape E.Becciolini A.Biggioggero M.Favalli E. G. Article (author) -
Sarilumab : patient-reported outcomes in rheumatoid arthritis 2018 Chiara CrottiMartina BiggioggeroAndrea BeccioliniEnnio Giulio Favalli Article (author) -
The profiling of axial spondyloarthritis patient candidate to a biologic therapy : consensus from a Delphi-panel of Italian experts 2018 Favalli E. G.Becciolini A.Caporali R. + Article (author) -
The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept : Retrospective analysis of a local registry 2018 Favalli E. G.Becciolini A.Biggioggero M.Crotti C.Raimondo M. G. + Article (author) -
Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors : real-life data from the LORHEN registry 2018 Favalli, Ennio G.Becciolini, AndreaSarzi-Puttini, P.Caporali, Roberto + Article (author) -
A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: Focus on interchangeability 2017 Becciolini A.Raimondo M. G.Crotti C.Agape E.Biggioggero M.Favalli E. G. Article (author) -
Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations : similarities and differences 2017 Favalli E. G.Becciolini A.Biggioggero M.Ughi N.Romano M.Crotti C.Meroni P. L. + Article (author) -
The 12-item psoriatic arthritis impact of disease questionnaire : Construct validity, reliability, and interpretability in a clinical setting 2017 Becciolini A.Crotti C.Favalli E. G. + Article (author) -
Spotlight on mavrilimumab for the treatment of rheumatoid arthritis : Evidence to date 2017 Crotti C.Raimondo M. G.Becciolini A.Biggioggero M.Favalli E. G. Article (author) -
The management of first-line biologic therapy failures in rheumatoid arthritis : current practice and future perspectives 2017 Favalli E. G.Raimondo M. G.Becciolini A.Biggioggero M.Caporali R. + Article (author) -
Change over time in the pattern of clinical response to first-line biologic drugs in patients with rheumatoid arthritis: Observational data in a real-life setting 2017 Favalli E. G.Becciolini A.Meroni P. L. Article (author) -
The role of methotrexate as combination therapy with etanercept in rheumatoid arthritis: Retrospective analysis of a local registry 2016 Becciolini A.Biggioggero M.Favalli E. G. Article (author) -
Eight-year retention rate of first-line tumor necrosis factor inhibitors in spondyloarthritis : A multi-center retrospective analysis 2016 E. G. FavalliC. SelmiA. BeccioliniM. Biggioggero + Article (author) -
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 2016 Cantini F.Nannini C.Favalli E. G.Becciolini A.Biggioggero M.Infantino M. + Article (author) -
Is there a need for new thresholds to define remission and low disease activity by disease activity score 28 calculated with C reactive protein? real life data from a local registry 2015 Favalli E. G.Becciolini A.Biggioggero M.Meroni P. L. + Article (author) -
Reliability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in patients with systemic sclerosis 2015 R. GualtierottiF. IngegnoliP.L. MeroniADORNI, GIUDITTAA. BeccioliniG. MarfiaL. ScaloneN. Ughi + Article (author) -
Structural integrity versus radiographic progression in rheumatoid arthritis 2015 Favalli E. G.Becciolini A.Biggioggero M. Article (author) -